Figure 4.
Interactions diagram of JAK1 kinase interactions with decernotinib (a), with KEV ligand (b), and with ruxolitinib (c); JAK2 kinases with decernotinib (d), with KEV ligand (e), and with ruxolitinib (f) (Supplementary materials, Figures S7–S12).

